WO2015087291A1 - 3-carboxy-4-(r)-phenylpyrrolydine-2-one salt and its use - Google Patents

3-carboxy-4-(r)-phenylpyrrolydine-2-one salt and its use Download PDF

Info

Publication number
WO2015087291A1
WO2015087291A1 PCT/IB2014/066846 IB2014066846W WO2015087291A1 WO 2015087291 A1 WO2015087291 A1 WO 2015087291A1 IB 2014066846 W IB2014066846 W IB 2014066846W WO 2015087291 A1 WO2015087291 A1 WO 2015087291A1
Authority
WO
WIPO (PCT)
Prior art keywords
carboxy
phenylpyrrolidine
salt
benzoyloxyquinuclidine
water
Prior art date
Application number
PCT/IB2014/066846
Other languages
French (fr)
Inventor
Galina KUHAREVA
Evgenij MATIUSHENKOV
Original Assignee
Jsc Olainfarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsc Olainfarm filed Critical Jsc Olainfarm
Priority to EA201691190A priority Critical patent/EA027373B1/en
Priority to UAA201606170A priority patent/UA114161C2/en
Publication of WO2015087291A1 publication Critical patent/WO2015087291A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • Current invention is generally related to intermediates for preparation of medicaments, namely to a novel process for the synthesis of 3-carboxy-4-(i?)-phenylpyrrolidine-2-one.
  • 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one may be converted by decarboxylation into known 4- (i?)-phenylpyrrolidine-2-one (Synthesis, (1991) 1023-1026), a useful starting material for preparation of N-carbamoylmethyl-4-(i?)-phenylpyrrolidine-2-one, which is known as the active enantiomer of the CNS agent Carphedon (WO2007104780).
  • 3-carboxy-4-(i?)-phenylpyrrolidine-2-one forms a strongly crystalline salt with 3-(5)-benzoyloxyquinuclidine, which is not known for being used for separation of enantiomers.
  • Said 3-(5)-benzoyloxyquinuclidine may be obtained by separation of the commercially available 3-(i?, ⁇ S)-benzoyloxyquinuclidine (INN: Benzoclidine), or by benzoylation of a commercially available 3-(5)-hydroxyquinuclidine, as it is described for the synthesis of racemate (Bioorg. &Med. Chem. Lett., 14, 3781-3784).
  • novel strongly crystalline 3-carboxy-4-(i?)- phenylpyrrolidine-2-one salt with 3-(5)-benzoyloxyquinuclidine may be easily obtained from a process, well scalable for industrial manufacture.
  • 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one salt with 3 -( ⁇ -benzoyl oxyquinuclidine is obtained in high yield and purity by reacting a racemic 3- carboxy-4-(i?,5)-phenylpyrrolidine-2-one with 3-(5)-benzoyloxyquinuclidine in a solvent, followed by recrystallization of the obtained crude salt.
  • solvent for this reaction and recrystallization is selected from the group comprising water, methanol, propalol-1, propanol-2 and acetonitrile.
  • the reaction of 3-carboxy-4-(i?,5)-phenylpyrrolidine-2-one with 3-(S)- benzoyloxyquinuclidine is performed in ethanol, and recrystallization of the 3-carboxy-4-(i?)- phenylpyrrolidine-2-one salt with 3-(5)-benzoyloxyquinuclidine is performed from water.
  • 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one may be obtained from the said salt by protonation with a suitable mineral acid solution in water, in the preferred embodiment using hydrochloric acid.
  • 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one which crystallizes from the solution may be further used without additional purification, but may also be recrystallized from water.
  • the current invention provides a novel easy method for obtaining 3-carboxy-4-(i?)- phenylpyrrolidine-2-one from the racemate, by using a new resolution reagent in industrially applicable solvent.
  • 3-Carboxy-4-(i?,5)-phenylpyrrolidine-2-one (210 g) was suspended in acetonitrile (520 ml). The suspension was heated to approx. 60 °C and 3-(5)-benzoyloxyquinuclidine (240 g) solution in acetonitrile (320 ml) was added upon stirring. The reaction mixture was stirred at this temperature for approx. 20 min and then was allowed to cool down to room temperature.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A novel method for obtaining 3-carboxy-4-(R)-phenylpyrrolidine-2-one from 3-carboxy-4- (R,S)-phenylpyrrolidine-2-one in which the racemic mixture is separated using 3-(S)- benzoyloxyquinuclidine.

Description

3-CARBOXY-4-(i?)-PHENYLPYRROLYDINE-2-ONE SALT AND ITS USE
Field of invention
Current invention is generally related to intermediates for preparation of medicaments, namely to a novel process for the synthesis of 3-carboxy-4-(i?)-phenylpyrrolidine-2-one.
Background of invention
3-Carboxy-4-(i?)-phenylpyrrolidine-2-one may be converted by decarboxylation into known 4- (i?)-phenylpyrrolidine-2-one (Synthesis, (1991) 1023-1026), a useful starting material for preparation of N-carbamoylmethyl-4-(i?)-phenylpyrrolidine-2-one, which is known as the active enantiomer of the CNS agent Carphedon (WO2007104780).
Separation of racemic 3-carboxy-4-phenylpyrrolidine-2-one by fractional crystallization of 3- carboxy-4-(i?)-phenylpyrrolidine-2-one cinchonidine salt is known in the art (Pol. J. Chem., 53 (1979) 435-446). However, this method is not applicable on an industrial scale because of the use of large amount of highly flammable solvents; it is time- and resources-consuming and is characterized by low and unstable yields.
An enzymatic synthesis of this optically active compound is known (LV13635 (2006)) but this method has several disadvantages like high cost and it is not suitable for large-scale production of this compound.
Taking into account that limitations of said methods cannot be negated, there is a need in development of a new suitable process, which can be used for industrial scale production and which is potentially of a high positive economic effect.
Description of invention
We have unexpectedly discovered, that 3-carboxy-4-(i?)-phenylpyrrolidine-2-one forms a strongly crystalline salt with 3-(5)-benzoyloxyquinuclidine, which is not known for being used for separation of enantiomers. Said 3-(5)-benzoyloxyquinuclidine may be obtained by separation of the commercially available 3-(i?,<S)-benzoyloxyquinuclidine (INN: Benzoclidine), or by benzoylation of a commercially available 3-(5)-hydroxyquinuclidine, as it is described for the synthesis of racemate (Bioorg. &Med. Chem. Lett., 14, 3781-3784).
According to the current invention, novel strongly crystalline 3-carboxy-4-(i?)- phenylpyrrolidine-2-one salt with 3-(5)-benzoyloxyquinuclidine may be easily obtained from a process, well scalable for industrial manufacture. 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one salt with 3 -(^-benzoyl oxyquinuclidine is obtained in high yield and purity by reacting a racemic 3- carboxy-4-(i?,5)-phenylpyrrolidine-2-one with 3-(5)-benzoyloxyquinuclidine in a solvent, followed by recrystallization of the obtained crude salt.
In the preferred embodiment, solvent for this reaction and recrystallization is selected from the group comprising water, methanol, propalol-1, propanol-2 and acetonitrile. In the most preferred embodiment, the reaction of 3-carboxy-4-(i?,5)-phenylpyrrolidine-2-one with 3-(S)- benzoyloxyquinuclidine is performed in ethanol, and recrystallization of the 3-carboxy-4-(i?)- phenylpyrrolidine-2-one salt with 3-(5)-benzoyloxyquinuclidine is performed from water.
3-Carboxy-4-(i?)-phenylpyrrolidine-2-one may be obtained from the said salt by protonation with a suitable mineral acid solution in water, in the preferred embodiment using hydrochloric acid. 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one which crystallizes from the solution may be further used without additional purification, but may also be recrystallized from water.
Thus, the current invention provides a novel easy method for obtaining 3-carboxy-4-(i?)- phenylpyrrolidine-2-one from the racemate, by using a new resolution reagent in industrially applicable solvent.
The current invention is illustrated by the following non-limiting examples.
Examples
Following examples are not deemed to limit the invention in any way and are used for demonstration purposes only.
Example 1. 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one salt with 3 -(^-benzoyl oxyquinuclidine.
3-Carboxy-4-(i?,5)-phenylpyrrolidine-2-one (210 g) was suspended in ethanol (570 ml). The suspension was heated to approx. 60 °C and 3-(5)-benzoyloxyquinuclidine (240 g) solution in ethanol (240 ml) was added upon stirring. The reaction mixture was stirred at this temperature for approx. 20 min and then was allowed to cool down to room temperature. Crystalline precipitate was filtered off and washed with ethanol (300 ml). The obtained salt was dried, then dissolved in hot water (750 ml), filtered and allowed to crystallize at room temperature for 2 h. Crystalline precipitate was filtered off, washed with water (200 ml) and dried. The yield was 160 g of a white crystalline salt. [a]D 20 (methanol, c = 2) = -55.7°; melting temp. 170-172 °C (decomp.).; C25H28N2O5, calc. %: C 68.79; H 6.47; N 6.42, found %: C 68.94; H 6.46; N 6.42.
Example 2. 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one salt with 3 -(^-benzoyl oxyquinuclidine.
3-Carboxy-4-(i?,5)-phenylpyrrolidine-2-one (210 g) was suspended in acetonitrile (520 ml). The suspension was heated to approx. 60 °C and 3-(5)-benzoyloxyquinuclidine (240 g) solution in acetonitrile (320 ml) was added upon stirring. The reaction mixture was stirred at this temperature for approx. 20 min and then was allowed to cool down to room temperature.
Crystalline precipitate was filtered off and washed with acetonitrile (170 ml). The obtained salt was dried, then dissolved in hot water (750 ml), filtered and allowed to crystallize at room temperature for 2 h. Crystalline precipitate was filtered off, washed with water (200 ml) and dried. The yield was 152 g of a white crystalline salt. [α]ϋ20 (methanol, c = 2) = -56.2°; melting temp. 170-172 °C (decomposition).
Example 3. 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one.
3-Carboxy-4-(i?)-phenylpyrrolidine-2-one salt with 3-(<S -benzoyloxyquinuclidine (160 g) was dissolved in water (700 ml) at 65 °C and concentrated HC1 (40 ml) was added dropwise until pH <3. Precipitation of white crystals of 3-carboxy-4-(i?)-phenylpyrrolidine-2-one was observed. Reaction mixture was cooled down to room temperature. After 2 h standing at the room temperature the precipitate was filtered off, washed with water (200 ml) at room temperature and dried in vacuum. 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one (70 g) was obtained as white crystalline solid (yield from racemate 34.3%), melting temp. 136.5 °C,
Figure imgf000004_0001
(methanol, c = 2) = -138.6°.

Claims

Claims
1. 3-Carboxy-4-(i?)-phenylpyrrolidine-2-one salt with 3 -(^-benzoyl oxyquinuclidine (I)
Figure imgf000005_0001
(I)
A method for obtaining 3-carboxy-4-(i?)-phenylpyrrolidine-2-one, characterized in that 3-carboxy-4-(i?,5)-phenylpyrrolidine-2-one is reacted with 3-(<S)- benzoyloxyquinuclidine in a solvent, followed by isolation of the obtained salt (I), purification and treatment with a mineral acid.
The method according to claim 2, wherein the solvent is selected from a group, comprising water, methanol, ethanol, propanol-1, propanol-2, acetonitrile and mixtures thereof.
4. The method according to claim 2, wherein the solvent is ethanol.
5. The method according to claim 2, wherein the solvent is acetonitrile.
6. The method according to claim 2, wherein the salt (I) purification is performed by crystallization from water.
The method according to claim 2, wherein the mineral acid is hydrochloric acid.
PCT/IB2014/066846 2013-12-13 2014-12-12 3-carboxy-4-(r)-phenylpyrrolydine-2-one salt and its use WO2015087291A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EA201691190A EA027373B1 (en) 2013-12-13 2014-12-12 Method for separating racemic 3-carboxy-4-phenylpyrrolydine-2-one using 3-(s)-benzoyloxyquinuclidine
UAA201606170A UA114161C2 (en) 2013-12-13 2014-12-12 3-CARBOXY-4- (R)-PHENYLPYROLIDINE-2-SALT SALT AND ITS USE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-13-209A LV15015B (en) 2013-12-13 2013-12-13 Salt of 3-carboxy-4-(r)-phenylpyrrolidinone-2 and uses thereof
LVP-13-209 2013-12-13

Publications (1)

Publication Number Publication Date
WO2015087291A1 true WO2015087291A1 (en) 2015-06-18

Family

ID=52462958

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2014/066846 WO2015087291A1 (en) 2013-12-13 2014-12-12 3-carboxy-4-(r)-phenylpyrrolydine-2-one salt and its use

Country Status (4)

Country Link
EA (1) EA027373B1 (en)
LV (1) LV15015B (en)
UA (1) UA114161C2 (en)
WO (1) WO2015087291A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007104780A2 (en) 2006-03-16 2007-09-20 Akciju Sabiedriba 'olainfarm' N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use
LV13635B (en) 2006-02-23 2008-01-20 Olainfarm As Enzymatic resolution of racemic 3-aryl-4-aminobutyric acids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13635B (en) 2006-02-23 2008-01-20 Olainfarm As Enzymatic resolution of racemic 3-aryl-4-aminobutyric acids
WO2007104780A2 (en) 2006-03-16 2007-09-20 Akciju Sabiedriba 'olainfarm' N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BIOORG. &MED. CHEM. LETT., vol. 14, pages 3781 - 3784
ELIEL E L ET AL: "CHEMICAL SEPARATION OF ENANTIOMERS VIA DIASTEREOMERS", STEREOCHEMISTRY OF ORGANIC COMPOUNDS, XX, XX, 1 January 1994 (1994-01-01), pages 322 - 336, XP002459712 *
POL. J. CHEM., vol. 53, 1979, pages 435 - 446
SOBOCINSKA, MARIA; ZOBACHEVA, MAIA M.; PEREKALIN, VSEVOLOD V.; KUPRYSZEWSKI, GOTFRYD: "Configuration of 4-aryl-2-pyrrolidinones and their 3-carboxy derivatives", POLISH JOURNAL OF CHEMISTRY, vol. 53, 1979, pages 435 - 446, XP002737419 *
SYNTHESIS, 1991, pages 1023 - 1026

Also Published As

Publication number Publication date
UA114161C2 (en) 2017-04-25
LV15015B (en) 2015-12-20
LV15015A (en) 2015-06-20
EA201691190A1 (en) 2016-12-30
EA027373B1 (en) 2017-07-31

Similar Documents

Publication Publication Date Title
US9150538B2 (en) Method for producing 4, 4-difluoro-3,4-dihydroisoquinoline derivatives
EA018227B1 (en) A method for the preparation of dabigatran and its intermediates
JP2021504418A (en) Method for producing 2- (5-methoxyisochroman-1-yl) -4,5-dihydro-1H-imidazole and its hydrogen sulfate
KR20120014005A (en) Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine
EP3653607B1 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
JP5622842B2 (en) Method for producing alkylamine derivative
JP2011236157A (en) Method for producing optically active nipecotic acid derivative
JP5403517B2 (en) Optically active 3-aminopyrrolidine salt, method for producing the same, and method for optical resolution of 3-aminopyrrolidine
JP4770826B2 (en) Method for producing 2-oxindole derivatives
JP6884857B2 (en) Method for producing phenylalanine compounds
WO2015087291A1 (en) 3-carboxy-4-(r)-phenylpyrrolydine-2-one salt and its use
WO2014009964A1 (en) Process for enantiomeric enrichment of 2 &#39;, 6 &#39; - pipecoloxylidide
US9611217B2 (en) Synthetic processes of carprofen
KR100881890B1 (en) Process for preparation of Sarpogrelate HCl salt
JP6477187B2 (en) Process for producing 2-amino-6-methylnicotinic acid ester
US9828334B2 (en) Process for preparing levomilnacipran
KR101613065B1 (en) Synthetic method of dihydroquinoline derivatives
JP2006001889A (en) Bactericidal pyridine compound
JP4913589B2 (en) One-pot production method of 1,2-benzisoxazole-3-methanesulfonamide
JP6239458B2 (en) Process for producing 2- (benzylsulfinyl) -1-cycloalkene-1-carboxylic acid ester
JP4545152B2 (en) Process for producing N-substituted 3β-aminonortropane
JP5704182B2 (en) Process for producing optically active tetrahydrofuran-2-carboxylic acid
CN102924375B (en) Talnetant intermediate, preparation method and applications thereof
JP2004250340A (en) Method for producing 4-hydrazinotetrahydropyrane compound or its acid salt
JP5142241B2 (en) Method for producing nicotinic acid ester compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14835578

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: A201606170

Country of ref document: UA

WWE Wipo information: entry into national phase

Ref document number: 201691190

Country of ref document: EA

122 Ep: pct application non-entry in european phase

Ref document number: 14835578

Country of ref document: EP

Kind code of ref document: A1